Crispr

Overview

Definition

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats): adaptive immune system in bacteria and archaea. Used as genome editing tool by harnessing Cas nucleases guided by RNA to target specific DNA sequences.

Function

Targets and cleaves foreign DNA sequences. Programmable specificity via guide RNA. Enables precise insertions, deletions, or replacements in genomes.

Significance

Transformative impact on genetic engineering, functional genomics, gene therapy, agriculture, and synthetic biology due to simplicity, efficiency, and versatility.

"CRISPR is the most significant advancement in molecular biology since PCR." -- Jennifer Doudna

Discovery and History

Initial Identification

1987: Repetitive DNA sequences discovered in Escherichia coli by Ishino et al. Named CRISPR in 2002 by Mojica et al.

Functional Elucidation

2005: Hypothesis of adaptive immunity function. 2007: Barrangou et al. demonstrated CRISPR confers bacteriophage resistance experimentally.

Development as Genome Editing Tool

2012: Doudna and Charpentier reengineered CRISPR-Cas9 for programmable DNA cleavage in vitro. 2013: Successful editing in eukaryotic cells by multiple groups.

Molecular Mechanism

Adaptation

Acquisition of foreign DNA fragments (spacers) into CRISPR array following infection.

Expression

Transcription of CRISPR locus into pre-crRNA, processing into mature crRNA.

Interference

crRNA forms complex with Cas proteins, guides nucleases to complementary DNA, inducing double-strand breaks (DSBs).

DNA Repair

Cell repairs DSB via non-homologous end joining (NHEJ) or homology-directed repair (HDR), enabling genome modifications.

1. Spacer acquisition: foreign DNA → CRISPR array2. crRNA biogenesis: pre-crRNA → mature crRNA3. Targeting: crRNA + Cas protein → DNA cleavage at protospacer4. DNA repair: NHEJ or HDR → mutation or insertion

Key Components

Cas Proteins

Classified into multiple types; Cas9 most widely used. Functions: DNA cleavage, target recognition.

Guide RNA (gRNA)

Engineered RNA combining crRNA and tracrRNA. Directs Cas9 to specific DNA sequences via base pairing.

Protospacer Adjacent Motif (PAM)

Short DNA sequence adjacent to target site required for Cas binding and cleavage. Common PAM: NGG for Cas9.

CRISPR Array

Repeats and spacers in bacterial genome storing memory of past infections.

Types of CRISPR Systems

Class 1

Multi-protein effector complexes. Examples: Type I, III. Less commonly used for genome editing.

Class 2

Single, multidomain effector proteins. Examples: Type II (Cas9), Type V (Cas12), Type VI (Cas13).

Cas9

Most studied. DNA endonuclease, requires PAM NGG. Used for double-strand breaks.

Cas12

Cleaves single-stranded DNA, exhibits collateral cleavage activity. PAMs vary.

Cas13

Targets RNA instead of DNA. Emerging tool for transcriptome editing.

Applications in Genetic Engineering

Gene Knockout

Disrupt gene function by inducing frameshift mutations via NHEJ.

Gene Correction

Precise gene edits by HDR with donor templates.

Gene Regulation

Dead Cas9 (dCas9) fused with activators/repressors for transcription modulation.

Functional Genomics

High-throughput screening of gene function using CRISPR libraries.

Agricultural Biotechnology

Crop trait improvements: disease resistance, yield enhancement, stress tolerance.

Gene Therapy

Potential treatment of genetic diseases by correcting mutations in somatic cells.

Delivery Methods

Viral Vectors

Adeno-associated virus (AAV), lentivirus: high efficiency, limited packaging size.

Non-viral Methods

Lipid nanoparticles, electroporation, microinjection: safer, transient expression.

Ribonucleoprotein Complexes

Direct delivery of Cas9 protein complexed with gRNA: reduces off-target effects, rapid action.

Physical Methods

Gene gun, hydrodynamic injection: limited use, specialized applications.

Delivery options:- Viral: AAV (4.7 kb capacity), Lentivirus (8-10 kb)- Non-viral: Lipofection, Electroporation- RNP: Cas9 + gRNA complex- Physical: Microinjection, Gene gun

Advantages and Limitations

Advantages

High specificity, ease of design, multiplexing capability, cost-effective, broad organism applicability.

Limitations

Off-target cleavage, PAM sequence dependency, mosaicism in embryos, delivery challenges, immune responses.

Improvement Strategies

Engineered high-fidelity Cas variants, base editors, prime editors, optimized delivery techniques.

Ethical Considerations

Germline Editing

Potential heritable changes raise safety, consent, societal impact issues.

Human Enhancement

Risks of non-therapeutic use: inequality, eugenics concerns.

Regulatory Frameworks

Vary globally; emphasize risk assessment, oversight, public engagement.

Animal and Environmental Impacts

Gene drives and ecological consequences require cautious evaluation.

Future Directions

Next-Generation Editors

Prime editing, base editing for precise, scarless modifications without DSBs.

Expanded Target Range

Discovery of new Cas proteins with diverse PAMs and nucleic acid targets.

Therapeutic Translation

Clinical trials for rare genetic disorders, cancer immunotherapy.

Synthetic Biology

Programmable cell circuits, metabolic pathway engineering.

Comparison with Other Gene Editing Tools

Zinc Finger Nucleases (ZFNs)

Protein-DNA recognition, complex design, lower multiplexing.

Transcription Activator-Like Effector Nucleases (TALENs)

Modular DNA binding, easier than ZFNs but labor-intensive.

CRISPR Advantages

Simpler design, RNA-guided, scalable, cost-effective, higher throughput.

Technical Challenges

Off-target Effects

Unintended DNA cleavage causing mutations. Mitigation via improved gRNA design, high-fidelity Cas variants.

Delivery Efficiency

Cell-type specificity, immune response, transient vs stable expression challenges.

Mosaicism

Incomplete editing in embryos or multicellular organisms leading to genetic heterogeneity.

DNA Repair Pathway Bias

NHEJ predominance limits precise editing; strategies to promote HDR ongoing.

Challenges and approaches:- Off-target: High-fidelity Cas9, truncated gRNAs- Delivery: Viral/non-viral optimization- Mosaicism: Timing of delivery, embryo stage targeting- DNA repair: Small molecules to enhance HDR

References

• Jinek, M. et al., "A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity," Science, vol. 337, 2012, pp. 816-821.
• Barrangou, R. et al., "CRISPR provides acquired resistance against viruses in prokaryotes," Science, vol. 315, 2007, pp. 1709-1712.
• Doudna, J.A., Charpentier, E., "The new frontier of genome engineering with CRISPR-Cas9," Science, vol. 346, 2014, 1258096.
• Mojica, F.J.M. et al., "Short motif sequences determine the targets of the prokaryotic CRISPR defence system," Microbiology, vol. 155, 2009, pp. 733-740.
• Koblan, L.W. et al., "Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction," Nature Biotechnology, vol. 36, 2018, pp. 843-846.